AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Tuesday, June 2, 2026 1 min read
Key Takeaway: AbbVie will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The management will engage in a fireside chat at 9:40 a.m. Central time, which will be accessible via a live audio webcast. An archived version will be available later the same day.
Price reaction · baseline $212.93 (2026-06-01 close) · hit after-hours · 1 other ABBV headline(s) in the window, move may be shared
day 0 close · peak
+1.2%
Market Sentiment Analysis
POSITIVE FACTORS
AbbVie is actively engaging in investor relations.
The presentation at a major conference highlights AbbVie's commitment to transparency.
The company is focused on innovative medicines and solutions.
Full Press Release Details
NORTH CHICAGO, Ill.,June 2, 2026/PRNewswire/ -- AbbVie (NYSE:ABBV) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026. Management will participate in a fireside chat at 9:40 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website atinvestors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie onLinkedIn,Facebook,Instagram,XandYouTube.